Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Tom P. Freeman*, Chandni Hindocha, Gianluca Baio, Natacha D.C. Shaban, Emily M. Thomas, Danica Astbury, Abigail M. Freeman, Rachel Lees, Sam Craft, Paul D. Morrison, Michael A.P. Bloomfield, Dominic O'Ryan, Jane Kinghorn, Celia J.A. Morgan, Ali Mofeez, H. Valerie Curran

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

139 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial'. Together they form a unique fingerprint.

Medicine and Dentistry